Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease

Clin Neuropharmacol. 2003 Jan-Feb;26(1):18-23. doi: 10.1097/00002826-200301000-00005.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / pathology
  • Humans
  • Huntington Disease / drug therapy*
  • Huntington Disease / pathology
  • Minocycline / adverse effects
  • Minocycline / therapeutic use
  • Neuroprotective Agents / adverse effects
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / pathology
  • Tetracyclines / adverse effects
  • Tetracyclines / therapeutic use*

Substances

  • Neuroprotective Agents
  • Tetracyclines
  • Minocycline